Quantum explicitly framed the investment as part of its ongoing fight against market corruption and manipulative trading.

If you want to know who really controls Xeris Biopharma Holdings, Inc. (NASDAQ:XERS), then you'll have to look at the makeup of its share registry. And the group that holds the bi ...

Nucleic acid therapies offer targeted treatment for genetic diseases, but delivery remains a key hurdle. Explore how advances ...

Speculation is in, conservatism is out as retail investors bid up questionable assets and imaginative financing exploits the ...

Flow Cytometry's growth accelerates as immuno-oncology and liquid biopsy markets expand, driving cancer research investment. Explore advancements in single-cell genomics and biotech opportunities in ...

Some of the biggest players in artificial intelligence continued to ramp up their spending on federal lobbying last quarter, ...

Novo Nordisk faces challenges in the competitive GLP-1 market, but its strong brand and R&D create opportunities for ...

Detailed price information for Quantum Biopharma Ltd (QNTM-Q) from The Globe and Mail including charting and trades.

Financial highlights in H1 2025 Reported revenues of €3,612m increased year-on-year by 5.7% and reached the highest level achieved by Eurofins in any ...

Industry breakthrough enabling high-yield (>99.9995%) microLED transfer LOS ANGELES, CA / ACCESS Newswire / July 22, 2025 / ...

Quantum BioPharma (NASDAQ: QNTM) , a biopharmaceutical company focused on neurodegenerative therapies, has purchased 2,000 shares of GameStop Corp. ( ...

Investing.com -- Quantum BioPharma Ltd. (NASDAQ: QNTM) stock fell 5.7% after the company announced it purchased 2,000 shares ...